IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sanofi

Q1 2026 Holdings

Filed 2026-05-07 | 9 holdings | $336.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MeiraGTx Holdings plc(MGTX)COMG59665102$105.6M12,197,73731.4%
Inhibrx Biosciences, Inc.(INBX)COM45720N103$77.8M1,157,92623.2%
Novavax(NVAX)COM NEW670002401$56.0M6,880,48116.7%
AnaptysBio(ANAB)COM032724106$30.4M821,9179.0%
Agomab Therapeutics NV(AGMB)SPONSORED ADS00860C102$29.2M2,783,0968.7%
MapLight Therapeutics Inc.(MPLT)COM56565P103$18.5M912,0415.5%
Immuneering Corp(IMRX)CLASS A COM45254E107$14.3M2,708,5594.2%
Eledon(ELDN)COM28617K101$2.5M814,9800.7%
Q32 Bio Inc.(QTTB)COM746964105$1.6M244,0830.5%